- 2022 - 2025 R3hdmlが切り開く筋腎連関の機序解明およびCKD・サルコペニアの新規治療戦略
- 2021 - 2024 新規に同定されたマイオカインを介した動脈硬化、NASH抑制効果の検証
- 2020 - 2023 サルコペニアの新たな治療戦略確立を目指した新規筋衛生細胞分泌蛋白の機能解析
- 2020 - 2023 Comprehensive study of risk factors and biomarkers that contribute to elucidation of the pathology of renal disorders due to aging and lifestyle
- 2017 - 2020 Elucidation of molecular pathology of aging and diseases based on multi-dimensional analysis of progeroid syndromes
- 2017 - 2020 Mechanism of sarcopenia based on analysis of Werner syndrome
- 2017 - 2020 Elucidation of the role of Tcf21 in renal fibrosis
- 2017 - 2020 Investigation of a novel myokine, R3hdml, on skeletal and bone metabolism and multiorgan association
- 2016 - 2019 Functional analysis of R3h domain containing-like, a novel skeletal satellite-cell-expressed gene, for investigating new treatment strategy of sarcopenia
- 2016 - 2019 The role of Semaphorin 3G in pathogenesis of NASH and NAFLD
- 2014 - 2017 Pathological elucidation of age-related diseases by integrative analyses of senescence genes
- 2014 - 2017 The role of Tcf21 in Podocytes in Health and Diseases
- 2014 - 2017 Investigation of the role of Semaphorin 3G in the homeostasis of pancreatic alpha cells and the application to the therapy against diabetes.
- 2014 - 2016 The role of Semaphorin signaling in pathogenesis of obesity and fatty liver -possible implication of gastrointestinal biota.
- 2012 - 2015 Investigation of the mechanism of cardiorenal syndrome through the functional analysis of Semaphorin 3G
- 2011 - 2015 Investigation of the mechanism of lifestyle-related diseases through the functional analysis of Semaphorin 3G, with the goal of developing a novel biomarker.
- 2011 - 2014 The role of lymphatic system and its functional failure in development of metabolic disorders.
- 2008 - 2010 Functional analysis of a novel glomerular specific gene and its application in the treatment of diabetic nephropathy.
- 2007 - 2008 慢性腎臓病、糖尿病性腎症、ネフローゼ症候群の機序解析と新しい治療法の開発
Show all